Towards Healthcare
Circadian Rhythm Sleep Disorder Market to Rise at 6.56% CAGR till 2034

Circadian Rhythm Sleep Disorder Market Sees Digital Shift

Market insights predict the global circadian rhythm sleep disorder industry will increase from USD 2.33 billion in 2024 to USD 4.38 billion by 2034, achieving a CAGR of 6.56%. The circadian rhythm sleep disorder market is growing due to the growing focus on occupational health and efforts taken by employers. North America captured the largest revenue in 2024 due to rising demand for digital health solutions to improve sleep health.

Content

  • Last Updated: 22 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The circadian rhythm sleep disorder market size was valued at US$ 2.33 billion in 2024 and is projected to grow to 2.48 billion in 2025. Forecasts suggest it will reach approximately US$ 4.38 billion by 2034, registering a CAGR of 6.56% during the period.

North America is currently leading the circadian rhythm sleep disorder market share by 45% due to occupational-related sleep disruptions and stress.

Some key players include Pfizer Inc., Compumedics Limited, Medtronic plc, Merck & Co., Inc., resMed Inc., etc.

Key trends include rising sleep disorders, mental health issues among teenagers, and growing awareness among populations about sleep disorder treatments.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions